Look for:

Our offer for

BIOGEN IDEC INC.


ISIN:
US09062X1037
WKN:
09062X103
2022/08/12 17:32:26
Price
215.90 EUR
Difference 1.65% (3.50)

General attributes

ISINUS09062X1037
SymbolBIIB
ExchangeVienna Stock Exchange
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)31,073 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)-
Ask (Ask size)-
Open213.30 EUR
High215.90 EUR
Low213.30 EUR
Close (prev. day)212.40 EUR
VWAP0.00 EUR
Volume (pcs)0
Trading volume0.00
Number of trades2
Last size0

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: BIOGEN IDEC INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/08/12 17:32:26
Price
215.90 EUR
Difference 1.65% (3.50)

General attributes

ISINUS09062X1037
SymbolBIIB
ExchangeVienna Stock Exchange
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)31,073 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)-
Ask (Ask size)-
Open213.30 EUR
High215.90 EUR
Low213.30 EUR
Close (prev. day)212.40 EUR
VWAP0.00 EUR
Volume (pcs)0
Trading volume0.00
Number of trades2
Last size0

Performance and Risk

6m1Y3Y
Perf (%)+13.01%-24.58%+5.15%
Perf (abs.)+24.86-70.35+10.57
Beta0.850.820.89
Volatility31.1632.2148.72
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)213.47 EUR (21)
Ø price 30 days | Ø volume 30 days (pcs.)210.73 EUR (9)
Ø price 100 days | Ø volume 100 days (pcs.)197.78 EUR (21)
Ø price 250 days | Ø volume 250 days (pcs.)212.19 EUR (68)
YTD High | date220.40 EUR (2022/07/20)
YTD Low | date175.00 EUR (2022/03/15)
52 Weeks High | date298.20 EUR (2021/08/25)
52 Weeks Low | date175.00 EUR (2022/03/15)

All listings for BIOGEN IDEC INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2022/08/1217:35215.70 EUR0.005
Vienna Stock Exchange2022/08/1217:32215.90 EUR0.002
Tradegate2022/08/1222:26215.35 EUR0.037
Stuttgart2022/08/1220:06215.60 EUR0.006
SIX Swiss Exchange2019/07/0217:35232.00 CHF0.001
Nasdaq2022/08/1222:00220.99 USD169.7119,789
Munich2022/08/1208:00212.10 EUR0.001
London Stock Exchange2022/05/3112:32206.2000 USD0.831
Hanover2022/08/1208:01212.10 EUR0.001
Hamburg2022/08/1208:01212.10 EUR0.001
Frankfurt2022/08/1215:33213.25 EUR0.013
Duesseldorf2022/08/1221:50215.30 EUR0.0011
Berlin2022/08/1221:45215.50 EUR0.0018

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2033&ID_TYPE_IMAGE_LOGO=2

Contact Details

BIOGEN INC.
- -
225 Binney Street - 02142 Cambridge
Telefon: 1-617-679-2000
Fax: -
E-mail: info@biogen.com

PDF Downloads

Company report: BIOGEN IDEC INC.PDF Download

Company Profile

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis, SPINRAZA for the treatment of spinal muscular atrophy, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Members of Management Board

Stelios PapadopoulosChairman of Board of Directors
Alexander DennerMember of Board of Directors
Eric RowinskyMember of Board of Directors
Maria FreireMember of Board of Directors
Richard MulliganMember of Board of Directors
Stephen SherwinMember of Board of Directors
Caroline DorsaMember of Board of Directors
Jesus MantasMember of Board of Directors
William HawkinsMember of Board of Directors
William JonesMember of Board of Directors
Michel VounatsosChairman of Managing Board
Ginger GregoryMember of Executive Committee
Alphonse GaldesMember of Executive Committee
Michael McDonnellMember of Executive Committee
Rachid IzzarMember of Executive Committee
Susan H. AlexanderMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer